¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"labile oxidase reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
¿µ¹® reaction formation ÇÑ±Û ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
¼³¸í   
  ¾ï¾Ðº¸´Ù ´õ Àû±ØÀûÀΠ¹æ¾î¸ÞÄ¿´ÏÁòÀ̸ç, ¹«ÀǽÄÀûÀΠ»ý°¢, ¼Ò¿ø, Ã浿ÀÌ ³Ê¹«³ªµµ ¹Þ¾Æµé¿©Áú ¼ö ¾ø´Â °ÍÀÏ °æ¿ì¿¡ À̿ʹ Á¤¹Ý´ë ¹æÇâÀÇ °ÍÀ» °­Á¶ÇÔÀ¸·Î½á ±×·± ¹«ÀǽÄÀûÀΠ°ÍµéÀÌ ÀǽĵÇÁö ¾Ê°Ô Çϴ °úÁ¤. ¿¹¸¦ µé¸é °¡Àå °¡ÇÐÀûÀΠ¼º°ÝÀÇ »ç¶÷ÀÌ »ýÃ¼ÇØºÎ ¹Ý´ë·ÐÀÚ°¡ µÇ´Â °æ¿ì¸¦ µé ¼ö ÀÖ´Ù. À̰ÍÀº ¶Ç °¡½¿ ±íÀÌ Àá°ÜÀִ µÎ·Á¿òÀÌ ÀǽĵǴ °ÍÀ» ÇÇÇϱâ À§Çؼ­ µÎ·Á¿òÀÇ ´ë»óÀÌ µÇ´Â Çൿ¿¡ °ñ¸ôÇϴ °æ¿ìµµ Æ÷ÇÔÀÌ µÈ´Ù. ¿¹¸¦ µé¸é, ³²ÀÚ¿¡°Ô »óó¹ÞÁö ¾ÊÀ»±î Çϴ µÎ·Á¿ò¿¡ °¡µæ Âù ¼Ò³à°¡ ÀÌ °°Àº µÎ·Á¿òÀ» ºÎÁ¤ÇÏ·Á´Â ¼ö´ÜÀ¸·Î ³­ÀâÇÑ ¼ºÇàÀ§¿¡ °ñ¸ôÇϴ °æ¿ì°¡ ÀÖ´Ù. ¶Ç ÀüóÀÇ Àڳฦ ¹Ì¿öÇϴ °è¸ð°¡ ¿ÀÈ÷·Á Áö³ªÄ¥ Á¤µµ·Î ±× ¾ÆÀ̸¦ ±Í¿©¿öÇϴ ÀÏ µûÀ§ÀÌ´Ù. 
¿µ¹® complement fixation reaction ÇÑ±Û º¸Ã¼°áÇÕ ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
¼³¸í   
  Ç×ü¿ÍÀÇ ¹ÝÀÀ¿¡ À־ º¸Ã¼¿Í °áÇÕÇϴ Ç×ü¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, ÀÌ ¹ÝÀÀÀº ÃÖÃÊ¿¡ ±âÁöÇ׿ø, ÇǰËÇ÷û ¹× º¸Ã¼¸¦ È¥ÇÕÇÑ´Ù. Á¦2´Ü°è¿¡¼­´Â ÀûÇ÷±¸¿Í À̰Ϳ¡ ´ëÀÀÇϴ ¿ëÇ÷¼ÒÀǠȥÇÕ¾×À» °¡ÇÑ´Ù. º» ¹ÝÀÀÈÄ ¿ëÇ÷ÀÌ ÀϾÁö ¾ÊÀ¸¸é º»Ã¼´Â Ç׿øÇ×ü°áÇÕ¹°¿¡ °áÇÕÇÑ °ÍÀÌ µÇ¾î ¾ç¼ºÀÌ µÇÁö¸¸, ¿ëÇ÷ÀÌ ÀϾ °æ¿ì º¸Ã¼´Â °áÇÕÇÏÁö ¾Ê¾Æ ¼ÒºñµÇÁö ¾Ê±â ¶§¹®¿¡ À½¼ºÀÌ µÈ´Ù. º» ¹ÝÀÀÀº ±âÁöÇ÷ûÀ» ½á¼­ Ç׿ø°ËÃâ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ¸¶ÀÌÄÚÇö󽺸¶, ¸®ÄÉí, Å¬¶ó¹Ìµð¾Æ, ¹ÙÀÌ·¯½º, ¸Åµ¶ µîÀÇ Áø´Ü¿¡ ¾²ÀδÙ.
  
  
¿µ¹® transfusion reaction ÇÑ±Û ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
¼³¸í   
  ¼öÇ÷ÇÏ¿´À» ¶§¿¡ È¯ÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù.
¿µ¹® graft versus host reaction ÇÑ±Û ÀÌ½ÄÆí´ë ¼÷ÁÖ¹ÝÀÀ
¼³¸í   
  ¸é¿ªÀ̶õ ÀÚ½ÅÀÇ °Í°ú ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» ±¸ºÐÇØ¼­ ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» °ø°ÝÇÏ¿© »ý¹°ÇÐÀû È°¼ºÀ» ¾ø¾Ö°Å³ª Á¦°ÅÇϴ °ÍÀÌ´Ù. ÀÌ ¸é¿ªÀº ÁַΠÇ÷¾×¿¡ Àִ ¼¼Æ÷¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. Æ¯È÷ ¸²ÇÁ±¸´Â ÀÌ ¸é¿ª¿¡ ÁßÃßÀûÀΠ¿ªÇÒÀ» Çϴ ¼¼Æ÷ÀÌ´Ù. ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀÀ̶ó´Â °ÍÀº À̽ĵǾî¿Â Á¶Á÷¿¡ Á¸ÀçÇϴ ŸÀÎÀÇ Ç÷±¸µéÀÌ ¼÷ÁÖÀÇ ¼¼Æ÷¸¦ °ø°ÝÇϴ °ÍÀ» ¸»ÇÑ´Ù. Áï À̽ĵǾî¿Â Á¶Á÷°ú ÇÔ²² µé¾î¿Â Ç÷±¸µéÀÌ À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¼¼Æ÷¸¦ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÇϴ Çö»óÀÌ´Ù. À̰ÍÀº À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¸é¿ª»óŰ¡ Á¤»óÀûÀÏ °æ¿ì¿¡´Â ÀϾÁö ¾Ê´Âµ¥ ¿Ö³ÄÇϸ頸鿪»óŰ¡ Á¤»óÀÏ °æ¿ì¿¡´Â À̽ĵǾî¿Â Àå±â¿Í ´õºÒ¾î µé¾î¿Â Å¸ÀÎÀÇ Ç÷±¸µéÀ» À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ Ç÷±¸°¡ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÀ» ÇÏ°í ¼ýÀûÀ¸·Î À¯¸®ÇÏ¿© ¸ðµÎ Á×ÀÏ ¼ö°¡ Àֱ⠶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • labile oxidase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidase reaction
    »êÈ­È¿¼Ò¹ÝÀÀ
  • oxidase
    »êÈ­È¿¼Ò
  • heat labile antibody
    ¿­¹Î°¨Ç×ü, ¿­ºÒ¾ÈÁ¤Ç×ü
  • heat-labile enterotoxin
    ¿­¹Î°¨Àåµ¶¼Ò
  • labile
    ºÒ¾ÈÁ¤-
  • labile affect
    ºÒ¾ÈÁ¤Á¤µ¿
  • labile factor
    1. ºÒ¾ÈÁ¤ÀÎÀÚ 2. ºÒ¾ÈÁ¤¿ä¼Ò
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • labile hypertension
    ºÒ¾ÈÁ¤°íÇ÷¾Ð
  • labile mood
    ºÒ¾ÈÁ¤±âºÐ
  • labile pulse
    ºÒ¾ÈÁ¤¸Æ¹Ú
  • anniversary reaction
    ÁÖ±â¹ÝÀÀ
  • anorectic reaction
    ½Ä¿å¾ïÁ¦¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • labile
    ºÒ¾ÈÁ¤-
  • oxidase
    »êÈ­È¿¼Ò
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction
    ¹ÝÀÀ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • cascade reaction
    ¿¬¼âÁõÆø¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • complement fixation reaction
    µµ¿òü°áÇÕ¹ÝÀÀ, º¸Ã¼°áÇÕ¹ÝÀÀ
  • cross reaction
    ±³Â÷¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidase reaction
    »êÈ­È¿¼Ò¹ÝÀÀ
  • labile oxydase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
  • cytochrome oxidase test
    ½ÃÅäÅ©·Ò»êÈ­È¿¼Ò°Ë»ç
  • oxidase
    »êÈ­È¿¼Ò
  • heat labile antibody
    ¿­¹Î°¨Ç×ü
  • labile affect
    À¯µ¿Á¤µ¿
  • heat-labile enterotoxin
    ¿­¹Î°¨Ã¢ÀÚµ¶¼Ò
  • labile factor
    ºÒ¾ÈÁ¤ÀÎÀÚ, ºÒ¾ÈÁ¤¿ä¼Ò
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â
  • heat-labile toxin
    ¿­¹Î°¨µ¶¼Ò
  • labile hemoglobin
    ºÒ¾ÈÁ¤Ç÷»ö¼Ò
  • labile hypertension
    (¢¡borderline hypertension) °æ°è°íÇ÷¾Ð
  • labile
    ºÒ¾ÈÁ¤-
  • labile mood
    ½±°Ôº¯Çϴ±âºÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heat labile
    ¿­ºÒ¾ÈÁ¤(æðÝÕäÌïÒ)ÀÎ, ÀÌ¿­¼º(ì¯æðàõ)
  • heat labile antibody
    ÀÌ¿­Ç×ü(ì¯æðù÷ô÷).
  • heat-labile enterotoxin
    ÀÌ¿­¼º Àåµ¶¼Ò
  • heat-labile toxin (LT)
    ÀÌ¿­¼ºµ¶¼Ò
  • GOD= glucose oxidase
    Æ÷µµ´ç»êÈ­ È¿¼Ò.
  • Kovacs oxidase reagent
    Äڹ齺 »êÈ­È¿¼Ò°Ë»ç½Ã¾à
  • MAO=£¾monoamine oxidase
    ¸ð³ë¾Æ¹Î»ê È­È¿¼Ò.
  • NADPH-dependent oxidase system
    NADPH-ÀÇÁ¸¼º »êÈ­È¿¼Ò°è
  • glucose oxidase
    Æ÷µµ´ç»êÈ­È¿¼Ò
  • glucose oxidase =GOD
    ±Û·çÄÚ¿À½º »êÈ­È¿¼Ò(¡­ß«ûùý£áÈ), ±Û·çÄÚ¿À½º¿Á½Ã ´ÙÁ¦.
  • histamine oxidase
    È÷½ºÅ¸¹Î¿Á½Ã´ÙÁ¦.
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê »êÈ­È¿¼Ò(¡­ß«ß«ûùý£áÈ).
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê»êÈ­È¿¼Ò
  • homogentisic oxidase
    È£¸ð°ÕƼ½Å»ê(Homogentisin) »êÈ­È¿¼Ò
  • indophenol oxidase
    ÀεµÆä³î»êÈ­È¿¼Ò.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • labile oxydase reaction
    ºÒ¾ÈÁ¤¿Á½Ã´Ù¾ÆÁ¦¹ÝÀÀ.
  • oxidase reaction
    »êÈ­È¿¼Ò¹ÝÀÀ(¡­Úãëë).
  • cell,labile
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)
  • enterotoxin, heat-labile
    ÀÌ¿­¼º Àåµ¶¼Ò
  • heat labile
    ¿­ºÒ¾ÈÁ¤(æðÝÕäÌïÒ)ÀÎ, ÀÌ¿­¼º(ì¯æðàõ)
  • heat labile antibody
    ÀÌ¿­Ç×ü(ì¯æðù÷ô÷).
  • heat-labile enterotoxin
    ÀÌ¿­¼º Àåµ¶¼Ò
  • heat-labile toxin (LT)
    ÀÌ¿­¼ºµ¶¼Ò
  • labile
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)(¼º).
  • labile affect
    À¯µ¿Á¤µ¿(ë´ÔÑïñÔÑ)
  • labile cells
    ºÒ¾ÈÁ¤ ¼¼Æ÷(ÝÕäÌïÒ á¬øà)
  • labile element
    ÇÙ ºÒ¾ÈÁ¤¿ø¼Ò(¡­ê«áÈ).
  • labile factor
    ºÒ¾ÈÁ¤ÀÎÀÚ, ºÒ¾ÈÁ¤¿ä¼Ò.
  • labile fraction
    ºÒ¾ÈÁ¤ºÐȹ(¡­ÝÂüñ).
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Reaction deficiency
    ¹ÝÀÀ°áÇÌ
    [¿¾ ¿ë¾î] ¹ÝÀÀ°áÇÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heat labile protein
    ¿­ºÒ¾ÈÁ¤ ´Ü¹éÁú
  • heat labile citrovorum factor
    ¿­ºÒ¾ÈÁ¤(æðÝÕäÌïÒ) ½ÃÆ®·Î¹ö·³ ÀÎÀÚ(ì×í­)
  • labile factor
    ºÒ¾ÈÁ¤ÀÎÀÚ(ÝÕäÌïÒì×í­)
  • labile methyl group
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)¸ÞÆ¿±â(Ðñ)
  • labile phosphate group
    ºÒ¾ÈÁ¤Àλê±â(ÝÕäÌïÒ×ò߫Ѩ)
  • labile proteins
    ºÒ¾ÈÁ¤´Ü¹éÁú(ÝÕäÌïÒÓ±ÛÜòõ)
  • labile sulfur
    ºÒ¾ÈÁ¤ Ȳ(ÝÕäÌïÒüÜ)
  • amino acid oxidase
    ¾Æ¹Ì³ë»ê(ß«) ¿Á½Ãµ¥À̽º
  • cholesterol oxidase
    ÄÝ·¹½ºÅ×·Ñ ¿Á½Ãµ¥À̽º
  • cytochrome c oxidase complex
    »çÀÌÅäÅ©·Ò c ¿Á½Ãµ¥À̽º º¹ÇÕü(ÜÜùêô÷) (ÔÒ) complex IV
  • cytochrome oxidase
    »çÀÌÅäÅ©·Ò ¿Á½Ãµ¥À̽º
  • mixed function oxidase
    È¥ÇÕ±â´É(ûèùêѦÒö)¿Á½Ãµ¥À̽º
  • monoamine oxidase
    ¸ð³ë¾Æ¹Î ¿Á½Ãµ¥À̽º
  • oxidase
    "¿Á½Ãµ¥À̽º, »êÈ­È¿¼Ò(ß«ûùý£áÈ)"
  • sulfite oxidase deficiency
    ¾ÆÈ²»ê(ä¬üÜß«) ¿Á½Ãµ¥À̽º °áÇÌ(ÌÀù¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • labile
    ºÒ¾ÈÁ¤
  • oxidase
    »êÈ­È¿¼Ò, ¿Á½Ã´ÙÁ¦
  • adverse reaction
    ºÎÀÛ¿ë, À¯ÇعÝÀÀ, À¯ÇØÀÛ¿ë, ¿ª¹ÝÀÀ
  • antigen antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • desmoid reaction
    Àδë¾ç¹ÝÀÀ
  • glial reaction
    ±³¼¼Æ÷ÀÛ¿ë,½Å°æ±³ÀÛ¿ë
  • hypersensitive reaction
    °ú¹Î¼º¹ÝÀÀ
  • leukemoid reaction
    ¹éÇ÷º´¾ç ¹ÝÀÀ
  • periosteal reaction
    °ñ¸·¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
LR labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l...
PAO peak acid output; peripheral airway obstruction; plasma amine oxidase; polyamine oxidase; pulmonary ...
LT   1) heat-Labile enteroToxin
  2) Leuko-Trience
HLF heat-labile factor; hepatic leukemia factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LT Heat-labile
LT Heat-labile enterotoxin
LT Heat-labile toxin
LT Labile Toxin
ALS acid labile subunit
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oxidase reaction
    »êÈ­ È¿¼Ò ¹ÝÀÀ
  • labile oxydase reaction
    ºÒ¾ÈÁ¤ ¿Á½Ã´Ù¾ÆÁ¦ ¹ÝÀÀ
  • cytochrome oxidase test
    »çÀÌÅäÅ©·Ò »êÈ­ È¿¼Ò °Ë»ç
  • histamine oxidase
    È÷½ºÅ¸¹Î ¿Á½Ã´ÙÁ¦
  • mixed function oxidase
    È¥ÇÕ ±â´É ¿Á½Ãµ¥À̽º
  • monoamine oxidase
    ¸ð³ë ¾Æ¹Î »êÈ­ È¿¼Ò, ¸ð³ë¾Æ¹Î ¿Á½Ã´ÙÁ¦
  • NADPH oxidase NADPH+2O2=NADP+ +2O2-ÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â »êÈ­ ȯ¿ø È¿¼ÒÀÇ ÇÑ Á¾·ùÀÌ´Ù. ÀÌ È¿¼Ò°èÀÇ À¯ÀüÀû °áÇÌÀº ¸¸¼º À°¾ÆÁ¾¼º ÁúȯÀ» À¯¹ßÇÑ´Ù.

    Nadsonieae

    ³ªµå¼Ò´Ï¾ÆÁ·
    È¿¸ð±Õ¾Æ°ú SaccharomycetoideaeÀÇ 1Á·À¸·Î, ±Õ»ç°¡ ¾ø°í, ·¹¸ó¸ð¾çÀÇ ºÐ¾Æ¼¼Æ÷°¡ ¹ß»ýÇÑ´Ù.
  • heat-labile toxin
    ÀÌ¿­¼º µ¶¼Ò
  • labile
    ȰÁÖ, ºÒ¾ÈÁ¤, ºÒ¾ÈÁ¤¼º
    1. ¸é À§¿¡¼­ ÇÑ ÁöÁ¡¿¡¼­ºÎÅÍ ÇÑ ÁöÁ¡±îÁöÀÇ ¿îµ¿. ºÒ¾ÈÁ¤ÇÑ. µ¿¿äÇÏ´Â. 2. È­ÇÐÀûÀ¸·Î ºÒ¾ÈÁ¤ÇÑ.
  • labile cell
    ºÒ¾ÈÁ¤ ¼¼Æ÷
  • labile factor
    ºÒ¾ÈÁ¤ ÀÎÀÚ, ºÒ¾ÈÁ¤ ¿ä¼Ò
  • labile glycogen
    ºÒ¾ÈÁ¤ ±Û¸®ÄÚ°Õ
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð
  • Abderhalden's reaction
    ¾Ðµ¥¸£ÇÒµ§ ¹ÝÀÀ
    ÀÌÁ¾ ´Ü¹éÁúÀÌ Ç÷¾× Áß¿¡ ħÀÔÇϸé, »ýü´Â À̰ÍÀ» ºÐÇØÇÏ´Â È¿¼Ò¸¦ »ý»êÇÔÀ¸·Î½á ÀÀ´äÇÑ´Ù´Â ±¸ °¡¼³¿¡ ±âÃÊÇÑ Ç÷û ¹ÝÀÀÀÌ´Ù. ÀÌ·¯ÇÑ ¹æ¾î È¿¼Ò´Â
  • accelerated reaction
    ÃËÁø ¹ÝÀÀ, °¡¼Ó ¹ÝÀÀ
    º¸Åë ¶§º¸´Ù ´Ü ½Ã°£ ³»¿¡ ÀϾ´Â ¹ÝÀÀ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
plasma labile factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
heat-labile Destroyed or altered by heat.
(05 Mar 2000)
labile 1. Gliding, moving from point to point over the surface, unstable, fluctuating.
2. <chemistry> Chemically unstable.
Origin: L. Labilis = unstable, from labi = to glide
(18 Nov 1997)
labile affect The rapid shifts in outward emotional expressions; often associated with organic brain syndromes such as intoxication.
(05 Mar 2000)
labile current An electrical current applied to the body by means of electrodes that are constantly shifted about.
(05 Mar 2000)
labile elements Tissue cells, as of epithelium, connective tissue, etc., that continue to multiply by mitosis during the life of the individual.
(05 Mar 2000)
labile factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
labile hypertension Frequently changing levels of elevated blood pressure.
(05 Mar 2000)
labile pulse Frequent changes in pulse rate.
(05 Mar 2000)
oxidase reaction The formation of indol blue when a blood smear containing myeloid leukocytes is treated with a mixture of alpha-naphthol and p-dimethylaniline sulfate; the myeloid leukocytes contain an oxidase that catalyses this reaction, the lymphoid leukocytes do not, in bacteriology, a reaction that depends on the presence of certain oxidases in some bacteria that catalyze the transport of electrons between electron donors in the bacteria and an oxidation reduction dye, such as tetramethyl-p-phenylenediamine; the dye is reduced to a blue or black colour.
(05 Mar 2000)
acetaldehyde oxidase <enzyme> Acetaldehyde is converted to acetate
Registry number: EC 1.2.-
(26 Jun 1999)
acyl-CoA oxidase <enzyme> Catalyses stoichiometric conversion of palmitoyl-CoA and o2 into 2-hexadecenoyl-CoA and h2o2; oxidises acyl-CoA's with carbon chain lengths of 4 to 20; most active toward lauroyl-CoA, but not acetyl- or succinyl-CoA
Registry number: EC 1.3.3.6
Synonym: fatty acyl CoA oxidase, fatty acyl-coenzyme a oxidase, fatty acid acyl-CoA oxidase, acox, pox1 gene product
(26 Jun 1999)
adrenaline oxidase amine oxidase (flavin-containing)
aldehyde oxidase <enzyme> Broad substrate specificity
Registry number: EC 1.2.3.1
Synonym: n1-methylnicotinamide oxidase I, n-nitrosoreductase
(26 Jun 1999)
alternative oxidase <enzyme> The terminal oxidase in alternative pathway respiration, as seen in plants like sauromatum guttatum (voodoo lily); amino acid sequence for tobacco alternative oxidase (aox1) in first source
Registry number: EC 1.-
Synonym: aox1 gene product, aox2 gene product, aox3 gene product
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • labile
    ºÒ¾ÈÁ¤ÇÑ;º¯È­¸¦ ÀÏÀ¸Å°±â½¬¿î
  • reaction
    ¹Ýµ¿
  • Feulgen reaction
    Æ÷ÀϰÕ(ÇÙ¿°»ö)¹ÝÀÀ
  • GVH reaction
    ´ë¼÷ÁÖ ÀÌ½ÄÆí ¹ÝÀÀ(ÀÌ½ÄµÈ Àå±â¿Í ü³» ¸é¿ª ¼¼Æ÷°£ÀÇ ¹ÝÀÀ)
  • atomic reaction
    ¿øÇÙ ¹ÝÀÀ
  • atonic reaction
    ¿øÀÚÇÙ¹ÝÀÀ
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • dark reaction
    (½Ä)¾Ï¹ÝÀÀ
  • exchange reaction
    (¹°)±³È¯ ¹ÝÀÀ
  • fightorfight reaction
    ¹æÀ§ ¹ÝÀÀÀÇ ÀÏÁ¾
  • fission chain reaction
    Çٺп­ ¿¬¼â ¹ÝÀÀ
  • fusion reaction
    ÇÙÀ¶ÇÕ ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • protective reaction
    ¹æ¾î ¹ÝÀÀ(ÀÚÀ§,º¸º¹À» ¸ñÀûÀ¸·Î ÇÑ Æø°Ý)
  • reaction
    ¹ÝÀÛ¿ë;¹ÝÇ×;¹Ý¹ß;(Á¤Ä¡»óÀÇ)¹Ýµ¿;¿ªÇà;(ÀÚ±Ø.»ç°Ç.¿µÇ⠵ ´ëÇÑ)¹ÝÀÀ;ŵµ;Àǰß;Àλó;(°ú·Î.±äÀå.ÈïºÐ ÈÄÀÇ)Ȱ·Â°¨Åð;¹«±â·Â;¹ÝÀÀ;¹ÝÀÛ¿ë;¹Ýµ¿·Â;ÇÙ¹ÝÀÀ;¹ÝÃæ ÀÛ¿ë;Àç»ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á